An Overview of Non-Medical Use of Prescription Drugs and Criminal Justice Issues in Canada

• Previous Page
• Table of Contents

Reference List

• Addictions Services Regina Qu'Appelle Health Region (2006).CCENDU Regina and Area 2004 Report Regina: Canadian Community Epidemiology Network on Drug Use.

• Adlaf, E., Begin, P., & Sawka, E. (2005a). Canadian Addiction Survey (CAS): a national survey of Canadians' use of alcohol and other drugs: prevalence of use and related harms - a detailed report. http://www.ccsa.ca/2005%20CCSA%20Documents/ccsa-004028-2005.pdf [On-line].

• Adlaf, E. & Pagila-Boak, A. (2005). Drug Use Among Ontario Students 1977-2005: OSDUS highlights. http://www.camh.net/pdf/OSDUS2005_HighlightsDrug_final.pdf [On-line].

• Adlaf, E., Demers, A., & Gliksman, L. (2005b).Canadian Campus Survey 2004 Toronto: Centre for Addiction and Mental Health.

• Adlaf, E. M. & Paglia-Boak, A. (2007). Drug use among Ontario students: Detailed OSDUHS findings: 1977-2007. http://www.camh.net/Research/Areas_of_research/Population_Life_Course_Studies/OSDUS/OSDUHS2007_DrugDetailed_final.pdf [On-line].

• Adlaf, E. M., Paglia-Boak, A., & Brands, B. (2006). Use of OxyContin by adolescent students.Canadian Medical Association Journal, 174, 1303.

• Anonymous (2005). Prescription opioid addiction leads many to methadone treatment.Alcoholism and Drug Abuse Weekly, 17, 1-3-5.

• Anthony, J., Warner, L., & Kessler, R. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the national comorbidity survey.Experimental & Clinical Psychopharmacology, 2, 244-268.

• Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K. et al. (2003).Alcohol: no ordinary commodity. Research and public policy. Oxford and London: Oxford University Press.

• Banta-Green, C., Merrill, J., Doyle, S., Boudreau, D., & Calsyn, D. (2009). Measurement of opioid problems among chronic pain patients in a general medical population.Drug and Alcohol Dependence, 104, 43-49.

• Barrett, S., Darredeau, C., & Pihl, R. (2006). Patterns of simultaneous polysubstance use in drug using university students.Human Psycholpharmacology, 21, 255-263.

• Beare, M. (2002). Organized corporate criminality - Tobacco smuggling between Canada and the US.Crime, Law and Social Change, 37, 225-243.

• Beau Dietl & Associates (2006)."You've Got Drugs!" Prescription drug pushers on the Internet: 2006 update. A CASA White Paper. New York: The National Center on Addiction and Substance Abuse at Columbia University.

• Becker, W., Fiellin, D., & Desai, R. (2007). Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: Psychiatric and socio-demographic correlates.Drug and Alcohol Dependence, 90, 280-287.

• Becker, W., Sullivan, L., Tetrault, J., Desai, R. A., & Fiellin, D. A. (2008). Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates.Drug and Alcohol Dependence, 94, 38-47.

• Bennett, D. & Carr, D. (2001). Opiophobia as a barrier to the treatment of pain. Journal of Pain and Palliative Care Pharmacotherapy, 16, 105-109.

• Birnbaum, H., White, A., Reynolds, J., Greenberg, P., Zhang, M., Vallow, S. et al. (2006). Estimated costs of prescription opioid analgesic abuse in the United States in 2001: A societal perspective.The Clinical Journal of Pain, 22, 667-676.

• Boyd, C. J., McCabe, S. E., & Teter, C. J. (2006). Medical and nonmedical use if prescription pain medication by youth in a Detroit area public school district.Drug and Alcohol Dependence, 81, 37-45.

• Boyd, CJ., McCabe, S. E., Cranford, JA., & Young, A. (2007). Prescription drug abuse and diversion among adolescents in a Southeast Michigan school district.Archives of Pediatrics & Adolescent Medicine, 161, 276-281.

• Boyer, E. & Wines, J. (2008). Impact of internet pharmacy regulation on opioid analgesic availability. Journal of Studies on Alcohol and Drugs 69[5], 703-708.

• Brands, B., Sproule, B., & Marshman, J. (1998).Drugs and Drug Abuse: A Reference Text. Toronto: Addiction Research Foundation. 3^rd Edition.

• Brands, B., Blake, J., & Marsh, D. (2002). Changing patient characteristics with increased methadone maintenance availability.Drug and Alcohol Dependence, 66, 11-20.

• Brands, B., Blake, J., Sproule, B., Gourlay, D., & Busto, U. (2004). Prescription opioid abuse in patients presenting for methadone maintenance treatment.Drug and Alcohol Dependence, 73, 199-207.

• Brushwood, D. (2003). Maximizing the value of electronic prescription monitoring programs.The Journal of Law, Medicine and Ethics, 31, 41-54.

• Busto, U., Bendayan, R., & Sellers, E. (1989). Clinical pharmacokinetics of non-opiate abused drugs.Clinical Pharmacokinetics, 16, 1-26.

• Busto, U., Romach, M., & Sellers, E. (1996). Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence.Journal of Clinical Psychopharmacology, 16, 51-57.

• Busto, U. & Sellers, E. (1991). Pharmacologic aspects of benzodiazepine tolerance and dependence.Journal of Substance Abuse Treatment, 8, 29-33.

• CCENDU (2004).Winnipeg 2004 Canadian Community Epidemiology Network on Drug Use Report Winnipeg: CCENDU.

• Charlson, F., Degenhardt, L., McLaren, J., Hall, W., & Lynskey, M. (2009). A systematic revew of research examining benzodiazepine-related mortality.Pharmacoepidemiology and Drug Safety, 18, 93-108.

• CHASE Project Team (2005).Community Health And Safety Evaluation (CHASE) Project: Final report Vancouver: Vancouver Coastal Health Authority.

• Cicero, T. J., Lynskey, M., Todorov, A., Inciardi, J. A., & Surratt, H. L. (2008a). Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse.Pain, 139, 127-135.

• Cicero, T. J., Shores, C., Paradis, A., & Ellis, M. (2008b). Source of drugs for prescription opioid analgesic abusers: A role for the internet? Pain Medicine 9[6], 718-723.

• College of Physicians and Surgeons of Alberta: (2004). Triplicate Prescription Program: Information for the pharmacist. http://www.cpsa.ca/wp-content/uploads/2015/09/Information_for_prescribers_and_dispensers.pdf [On-line].

• Community Epidemiology Work Group (2008).Epidemiologic trends in drug abuse: Proceedings of the Community Epidemiology Work Group. Volume II Bethesda, MD: Division of Epidemiology, Services and Prevention Research. National Institutes of Health.

• Compton, W. M. & Volkow, N. D. (2006). Major increases in opioid analgesic abuse in the United States: concerns and strategies.Drug and Alcohol Dependence, 81, 103-107.

• Covell, K. (2004).Adolescents and drug use in Cape Breton: A focus on risk factors and prevention Cape Breton: Children's Rights Centre, University College of Cape Breton.

• Curtis, L., Stoddard, J., Radeva, J., Hutchison, S., Dans, P., Wright, A. et al. (2006). Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States.Health Services Research, 41, 837-855.

• Darke, A. & Stewart, J. (1999). Efficacy and abuse potential of opioid analgesics and the treatment of chronic noncancer pain.Pain Research and Management, 4, 104-109.

• Darke, S., Degenhardt, L., & Mattick, R. (2007).Mortality amongst illicit drug users: Epidemiology, causes and intervention. Cambridge: Cambridge University Press.

• Darke, S. & Zador, D. (1996). Fatal heroin "overdose": a review.Addiction, 91, 1764-1772.

• Dauvergne, M. (2009). Trends in police-reported drug offences in Canada.Juristat, 29.

• Davis, W. & Johnson, B. (2008). Presciption opioid use, misuse, and diversion among street drug users in New York City.Drug and Alcohol Dependence, 92, 267-276.

• Dekker, A. (2007). What is being done to address the new drug epidemic?Journal of the American Osteopathic Association, 107, ES21-ES26.

• Department of Health and Human Services (2009). Treatment Episode Data Sets (TEDS) Highlights - 2007. National admissions to substance abuse treatment services. http://wwwdasis.samhsa.gov/teds07/tedshigh2k7.pdf [On-line].

• Dhalla, I., Mamdani, M., Sivilotte, M., Kopp, A., Qureshi, O., & Juurlink, D. (2009). Opioid analgesic prescribing and mortality before and after the introduction of long-acting oxycodone in Ontario.Canadian Medical Association Journal, In Press

• Dowling, K., Storr, C. L., & Chilcoat, H. D. (2006). Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population.Clinical Journal of Pain, 22, 776-783.

• Drug and Alcohol Treatment Information System (DATIS) (2008). Substance abuse statistical tables. http://www.datis.ca/download/SA%20Statistical%20Tablesv1.pdf [On-line].

• Egger M, Smith GD, Altman DG (2001).Systematic reviews in health care. Meta-analysis in context.London, UK: BMJ Books.

• El-Aneed, A., Alaghehbandan, R., Gladney, N., Collins, K., MacDonald, D., & Fischer, B. (2009). Prescription drug abuse and methods of diversion: The potential role of a pharmacy network.J Subst Use, 14, 75-83.

• Epidemiology and Disease Control and Population Health Surveillance Unit (2006).I-Track Survey: Enhanced surveillance of risk behaviours and prevalence of HIV and hepatitis C among people who inject drug: Victoria site report Victoria: Vancouver Island Health Authority and Public Health Agency Canada.

• Fanton, L., Bévalot, F., Schoendorff, P., Lalliard, S., Jdeed, K., & Malicier, D. (2007). Toxicologic aspects of deaths due to falls from height.American Journal of Forensic Medical Pathology, 28, 262-266.

• Fernandez, C., Stutzer, C., MacWilliam, L., & Fryer, C. (1998). Alternative and complementary therapy use in pediatric oncology in British Columbia: prevalence and reasons for use and nonuse.Journal of Clinical Oncology, 16, 1279-1286.

• Firestone-Cruz, M. & Fischer, B. (2008). A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availability.Harm Reduction Journal, 5, 30.

• Fischer, B. (1999). Prohibition, public health and a window of opportunity: An analysis of Canadian drug policy, 1985-1997.Policy Studies, 20, 197-210.

• Fischer, B. (2003). Illegale Opiatsucht, Behandlung und ökonomische Kostenforschung - ein beispielhafter Überblick und eine Diskussion aus sozialwissenschaftlicher Perspektive [Illicit opioid dependence, treatment and economic cost research - a selective review and discussion from a social science perspective].Sucht, 4, 2-7.

• Fischer, B., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N., Noel, L. et al. (2004). Determinants of overdose incidents among illicit opioid users in 5 Canadian cities.Canadian Medical Association Journal, 171, 235-239.

• Fischer, B., De Leo, J., Allard, C., Firestone Cruz, M., Patra, J., & Rehm J. (2009a). Exploring drug sourcing among regular prescription opioid users in Canada: Data from Toronto and Victoria.Canadian Journal of Criminology and Criminal Justice, 51, 55-72.

• Fischer, B., Gittins, J., Kendall, P., & Rehm J. (2009b). Thinking the unthinkable: Could the increasing misuse of prescription opioids among street drug users offer benefits for public health?Public Health, 123, 145-146.

• Fischer, B., Manzoni, P., & Rehm, J. (2006a). Comparing injecting and non-injecting illicit opioid users in a multisite Canadian sample (OPICAN cohort).European Addiction Research, 12, 230-239.

• Fischer, B., Nakamura, N., Rush, B., Rehm, J., & Urbanoski, K. (2009c). Changes in and characteristics of admissions to substance use treatment related to problematic prescription opioid use in Ontario, 2004-2009.Canadian Medical Association Journal, Submitted

• Fischer, B., Patra, J., Firestone Cruz, M., Gittins, J., & Rehm, J. (2008a). Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users.Drug and Alcohol Review, 27, 625-632.

• Fischer, B. & Rehm, J. (2008). Nonmedical use of prescription opioids: Furthering a meaningful research agenda.J Pain, 9, 490-493.

• Fischer, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N. et al. (2005). Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study).Journal of Urban Health, 82, 250-266.

• Fischer, B., Rehm, J., Patra, J., & Firestone Cruz, M. (2006b). Changes in illicit opioid use profiles across Canada.Canadian Medical Association Journal, 175, 1-3.

• Fischer, B., Gittins, J., & Rehm, J. (2008b). Characterizing the 'awakening elephant': prescription opioid misuse in North America: Epidemiology, harms, interventions.Contemporary Drug Problems, 35, 397-426.

• Fischer, B., Rehm, J., Goldman, B., & Popova, S. (2008c). Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development.Canadian Journal of Public Health, 99, 182-184.

• Fischer, B., Single, E., Room, R., Poulin, C., Sawka, E., Thompson, H., & Topp, J. (1998). Cannabis use in Canada: Policy options for control.Policy Options,34-38

• Fishman, S. M., Papazian, J. S., Gonzalez, S., Riches, P. S., & Gilson, A. (2004). Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.Pain Medicine, 5, 309-324.

• Fishman, S. (2006). Commentary in response to Paulozzi et al: prescription drug abuse and safe pain management.Pharmacoepidemiology and Drug Safety, 15, 628-631.

• Forman, R. F. (2006). Innovations: alcohol & drug abuse: narcotics on the net: the availability of web sites selling controlled substances.Psychiatric Services, 57, 24-6.

• Friesen, K., Lemaire, J., & Patton, D. (2008).Alcohol and other drugs: Students in Manitoba - 2007 Addictions Foundation of Manitoba.

• Garvin, F. (2004).Safe comminity coalition of Brockville and District Leeds and Grenville 2004 CCENDU/HEP Report Brockville: Canadian Community Epidemiology Network on Drug Use & Health, Education and Enforcement Partnership.

• Giffen, J., Endicott, S., & Lambert, S. (1991).Panic and Indifference - The Politics of Canada's Drug Laws. Ottawa: Canadian Centre on Substance Abuse.

• Gilbody, S., Wilson, P., & Watt, I. (2005). Benefits and harms of direct to consumer advertising: a systematic review.BMJ Quality and Safety in Health Care, 14, 246-250.

• Gilson, A., Ryan, K., Joranson, D. E., & Dahl, J. (2004). A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control.Journal of Pain and Symptom Management, 28, 176-188.

• Gliksman, L., Demers, A., Adlaf, EM., Newton-Taylor, B., & Schmidt, K. (2000).Canadian Campus Survey 1998 Toronto: Centre for Addiction and Mental Health.

• Goldman, B. (2002). Drug-seeking behaviour. In R.Jovey (Ed.),Managing Pain: The Canadian healthcare professional's reference (pp. 77-86). Toronto: Rogers Publishing.

• Goldman, B. (2008). Drug-seeking behaviour. In R.Jovey (Ed.), (pp. 119-136). Toronto: Rogers Media.

• Goldstein, P. (1985). The drugs/violence nexus: A tripartite conceptual framework.Journal of Drug Issues, 15, 493-506.

• Goodwin, R. & Hasin, D. (2002). Sedative use and misuse in the United States.Addiction, 97, 555-562.

• Govitrapong, P., Suttitum, T., Kotchabhakdi, N., & Uneklabh, T. (1998). Alternations of immune functions in heroin addicts and heroin withdrawal subjects.Journal of Pharmacology and Experimental Therapeutics, 286, 883-889.

• Hamilton, I., Reay, L., & Sullivan, F. (1990). A survey of general practitioners' attitudes to benzodiazepine overprescribing.Health Bulletin (Edinb), 48, 299-303.

• Haydon, E., Rehm, J., Fischer, B., Monga, N., & Adlaf, E. (2005). Prescription Drug Abuse in Canada and the Diversion of Prescription Drugs into the Illicit Drug Market.Canadian Journal of Public Health, 96, 459-461.

• Health Canada (2004). I-Track: Enhanced Surveillance of Risk Behaviours among Injecting Drug Users in Canada (Pilot Survey Report). http://www.phac-aspc.gc.ca/i-track/psr-rep04/pdf/i-track_pilot_survey_report_feb-2004_e.pdf [On-line].

• Health Canada (2006). I-Track: Enhanced surveillance of risk behaviours among injecting drug users in Canada - Phase I Report. http://www.phac-aspc.gc.ca/i-track/sr-re-1/pdf/itrack06_e.pdf [On-line].

• Health Canada (2009). Canadian Alcohol and Drug Use Monitoring Survey: Summary Results for 2008. http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2008/summary-sommaire-eng.php [On-line].

• Hegeman, J., van den Bemt, B., Duysens, J., & van Limbeek, J. (2009). NSAIDs and the risk of accidental falls in the elderly: a systematic review.Drug Safety, 32, 489-498.

• Hollenberg, D. (2006). Uncharted ground: Patterns of professional interaction among complementary/alternative and biomedical practitioners in integrative health care settings.Social Science and Medicine, 62, 731-744.

• Huang, B., Dawson, D., Stinson, F. S., Hasin, D. S., Ruan, W., Saha, T. et al. (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions.Journal of Clinical Psychiatry, 67, 1062-1073.

• Hurwitz, W. (2005). The challenge of prescription drug misuse: A review and commentary.Pain Medicine, 6, 152-161.

• Ialomiteanu, A.R., Adlaf, E.M., Mann, R.E., & Rehm J. (2009).CAMH Monitor eReport.Addiction and mental health indicators among Ontario adults 1977-2007.Toronto: Centre for Addiction and Mental Health.

• Ialomiteanu, A & Adlaf, E.M. (2009). CAMH Monitor 2008: Technical Guide. Toronto, Centre for Addiction and Mental Health. http://www.camh.net/Research/camh_monitor.html [On-line unpublished data]

• Inciardi, J., Surratt, H. L., Kurtz, S., & Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.Pain Medicine, 8, 171-183.

• Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Burke, J. (2006). The diversion of prescription drugs by health care workers in Cincinnati, Ohio.Substance Use and Misuse, 41, 255-264.

• Inciardi, J., Surratt, H. L., Cicero, T. J., & Beard, R. (2009). Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment.Pain Medicine, 10, 537-548.

• International Narcotics Control Board (2001).Report for the International Narcotics Control Board for 2001 New York: United Nations.

• International Narcotics Control Board (2002).Narcotic Drugs: Estimated world requirements for 2003- Statistics for 2001 New York: United Nations.

• International Narcotics Control Board (2004).Narcotic Drugs: Estimated world requirements for 2005. Statistics for 2003 New York: United Nations.

• International Narcotics Control Board (2005a).Narcotic Drugs: Estimated world requirements for 2006. Statistics for 2004. New York: United Nations.

• International Narcotics Control Board (2005b).Psychotropic Substances: Statistics for 2004. Assessment of annual medical and scientific requirements for substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 New York: United Nations.

• International Narcotics Control Board (2008a). Narcotic drugs: Estimated world requirements for 2009. Statistics for 2007. http://www.incb.org/pdf/technical-reports/narcotic-drugs/2008/narcotics_drugs_2008.pdf [On-line].

• International Narcotics Control Board (2008b).Psychotropic Substances: Statistics for 2007. Assessment of annual medical and scientific requirements for substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 New York: United Nations.

• International Narcotics Control Board (2009a).Narcotic drugs: Estimated world requirements for 2009. Statistics for 2007 New York: United Nations.

• International Narcotics Control Board (2009b).Psychotropic Substances: Statistics for 2007. Assessment of annual medical and scientific requirements for substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 New York: United Nations.

• International Narcotics Control Board (2009c).Psychotropic Substances: Statistics for 2008. Assessment of annual medical and scientific requirements for substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 New York: United Nations.

• Jerian, K. (2006). What's a legal system to do? The problem of regulating Internet pharmacies.Albany Law Review of Science and Technology, 16, 571-598.

• Joossens, L. & Raw, M. (2000). How can cigarette smuggling be reduced?British Medical Journal, 321, 947-950.

• Joranson, D. E. & Gilson, A. (2007). A much-needed window on opioid diversion.Pain Medicine, 8, 128-129.

• Joranson, D. E. & Gilson, A. (2006). Wanted: a public health approach to prescription opioid abuse and diversion.Pharmacoepidemiology and Drug Safety, 15, 632-634.

• Joranson, D., Carrow, G., Ryan, K., Shaefer, L., Gilson, A., Good, P. et al. (2002). Pain management and prescription monitoring.Journal of Pain and Symptom Management, 23, 231-238.

• Kaye, S., Darke, S., Duflou, J., & McKetin, R. (2008). Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.Addiction, 103, 1353-1360.

• Kelly, E., Darke, S., & Ross, J. (2004). A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions.Drug and Alcohol Review, 23, 319-344.

• Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications.Harvard Review of Psychiatry, 4, 231-224.

• Lane, J. & AADAC Research Services (2006).The Alberta Youth Experience Survey (TAYES) 2005 Alberta Alcohol and Drug Abuse Commission (AADAC).

• Lankenau, S. E., Sanders, B., Jackson Bloom, J., Hathazi, D., Alarcon, E., Tortu, S. et al. (2007). Prevalence and patterns of prescription drug misuse among young ketamine injectors.Journal of Drug Issues, 37, 717-736.

• Lenton, S. & Heale, P. (2000). Arrest, court and social impacts of conviction for a minor cannabis offence under strict prohibition.Contemporary Drug Problems, 27, 805-833.

• Lenton, S., Humeniuk, R., Heale, P., & Christie, P. (2000). Infringement versus conviction: the social impact of a minor cannabis offence in South Australia and Western Australia.Drug and Alcohol Review, 19, 257-264.

• Leri, F., Stweart, J., Fischer, B., Rehm, J., & et al (2005). Patterns of opioid and cocaine co-use: A descriptive study in a Canadian sample of untreated opioid-dependent individuals.Experimental & Clinical Psychopharmacology, 13, 303-310.

• Levy, M. (2007). An exploratory study of OxyContin use among individuals with substance use disorder.Journal of Psychoactive Drugs, 39, 271-276.

• Littlejohn, C., Baldacchino, A., Schifano, F., & Deluca, P. (2005). Internet pharmacies and online prescription drug sales: A cross-sectional study.Drugs: Education, Prevention & Policy, 12, 75-80.

• MacCoun, R. & Reuter, P. (2001).Drug War Heresies: Learning from other vices, times, and places. Cambridge University Press.

• Maddox, L. & Katsanis, L. (1997). Direct-to-consumer advertising of prescription drugs in Canada: Its potential effect on patient-physician interaction.Journal of Pharmaceutical Marketing and Management, 12, 1-21.

• Manzoni, P, Brochu, S, Fischer, B, and Rehm, J (2006). Determinants of Property Crime Among Illicit Opiate Users Outside of Treatment Across Canada.Deviant Behaviour, 27, 351-376.

• Martin, C. (2008). Prescription drug abuse in the elderly.Consultant Pharmacist, 23, 930-934.

• Martin, T. L., Woodall, K. L., & McLellan, B. A. (2006). Fentanyl-related deaths in Ontario, Canada: Toxicological findings and circumstances of death in 112 cases (2002-2004).J Analytical Toxicology, 30, 603-610.

• Martyres, R. F., Clodes, D., & Burns, J. M. (2004). Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose.Medical Journal of Australia, 180, 211-214.

• Maurer, H. (2009). Mass spectrometric approaches in impaired driving toxicology.Analytical and Bioanalytical Chemistry, 393, 97-107.

• McCabe, S. E. & Boyd, C. J. (2005). Sources of prescription drugs for illicit use.Addictive Behaviors, 30, 1342-1350.

• McCabe, S. E., Boyd, C. J., & Teter, C. J. (2006). Medical use, illicit use, and diversion of abusable prescription drugs.Journal of American College Health, 54, 269-278.

• McCabe, S. E., Cranford, JA., Boyd, CJ., & Teter, CJ. (2007). Motives, diversion and routes of administration associated with nonmedical use of prescription opioids.Addictive Behaviors, 32, 562-575.

• Miller, N., Greenfeld, & A (2004). Patient characteristics and risk factors for development of dependence on hydrocodone and oxycodone.American Journal of Therapeutics, 11, 26-32.

• Mintzes, B., Barer, M., Kravitz, R., Kazanjian, A., Bassett, K., Lexchin, J. et al. (2002). Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey.British Medical Journal, 324, 278-279.

• Mitka, M. (2000). Abuse of prescription drugs: Is a patient ailing or addicted?Journal of the American Medical Association, 283, 1126-1127.

• Monga, N., Rehm, J., Fischer, B., Brissette, S., Bruneau, J., el-Guebaly, N. et al. (2007). Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users.Drug and Alcohol Dependence, 8, 1-7.

• Morgan, J. (1985). American Opiophobia: Customary underutilization of opioid analgesics.Advances in Alcohol and Substance Abuse, 5, 163-172.

• Morgan, S., Raymond, C., Mooney, D., & Martin, D. (2008). The Canadian Rx Atlas: 2nd Edition. http://www.chspr.ubc.ca/files/publications/2008/CanRxAtlas/Canadian_Rx_Atlas_2nd_Edition.pdf [On-line].

• Nielsen, S. & Barratt, M. (2009). Prescription drug misuse: Is technology friend or foe?Drug and Alcohol Review, 28, 81-86.

• Novak, S., Herman-Stahl, M., Flannery, B., & Zimmerman, M. (2009). Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States.Drug and Alcohol Dependence, 100, 63-70.

• Office of Diversion Control, U. D. o. J. D. E. A. (2008). Questions and Answers - State prescription drug monitoring programs. http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm [On-line].

• OxyContin Task Force (2004). OxyContin Task Force: Final Report. http://www.health.gov.nl.ca/health/publications/oxyfinal/OxyContinFinalReport.pdf [On-line].

• Passik, S. D., Hays, L., Eisner, N., & Kirsh, K. (2006). Psychiatric and pain characteristics of prescription drug abusers entreing drug rehabilitation.Journal of Pain and Palliative Care Pharmacotherapy, 20, 5-13.

• Patra, J., Fischer, B., Maksimowska, S., & Rehm, J. (2009). Profiling poly-substance use typologies in a multi-site cohort of illicit opioid and other drug users in Canada - a latent class analysis (LCA).Addiction Research and Theory, 17, 168-185.

• Paulozzi, L., Budnitz, D., & Xi, Y. (2006). Increasing deaths from opioid analgesics in the United States.Pharmacoepidemiology and Drug Safety, 15, 618-627.

• Paulozzi, L., Logan, J., Hall, A., McKinstry, E., Kaplan, J., & Crosby, A. (2009). A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia.Addiction, 104, 1541-1548.

• Paulozzi, L. & Yongli, X. (2008). Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type.Pharmacoepidemiology and Drug Safety, 17, 997-1005.

• Popova, S., Patra, J., Mohapatra, S., Fischer, B., & Rehm J. (2009). How many people in Canada use prescription opioids non-medically in general and street drug using populations?Canadian Journal of Public Health, 100, 104-108.

• Poulin, C. & Elliot, D. (2007). Student Drug Use Survey in the Atlantic Provinces 2007: Atlantic Technical Report. http://www.health.gov.nl.ca/health/publications/pdfiles/Atl_Tech_Report_2007_web_cover.pdf [On-line].

• RCMP Criminal Intelligence (2008). Drug situation in Canada 2007. http://publications.gc.ca/collections/collection_2009/grc-rcmp/PS61-14-2007E.pdf [On-line].

• Rehm, J., Baliunas, D., Brochu, S., Fischer, B., Gnam, W., Patra, J. et al. (2006).The costs of substance abuse in Canada 2002. Ottawa, Canada: Canadian Centre on Substance Abuse (CCSA).

• Research Group on Drug Use (2004).Drug Use in Toronto Toronto: Research Group on Drug Use.

• Rhodin, A. (2006). The rise of opiophobia. Is history a barrier to prescribing?Journal of Pain and Palliative Care Pharmacotherapy, 20, 31-32.

• Rogers, A., Pilgrim, D., Brennan, S., Sulaiman, I., Watson, G., & Chew-Graham, C. (2007). Prescribing benzodiazepines in general practice: a new view of an old problem.Health, 11, 181-198.

• Romach, M., Sproule, B., Sellers, E., Somer, G., & Busto, U. (1999). Long-term codeine use is associated with depressive symptoms.Journal of Clinical Psychopharmacology, 19, 373-376.

• Room, R., Fischer, B., Hall, W., Lenton, S., & Reuter, P. (2008).The Global Cannabis Commission Report: Cannabis Policy: Moving beyond Stalemate Oxford: Beckley Foundation and Oxford University Press.

• Rosenblum, A., Parrino, M., Schnoll, S., Fong, C., Maxwell, C., Cleland, C. et al. (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment.Drug and Alcohol Dependence, 90, 64-71.

• Rush, B. (2002). Client characteristics and patterns of service utilization within Ontario's specialized addiction treatment agencies: A provincial report from DATIS. April 1, 1999 - March 31, 2000. http://www.datis.ca/download/DATISClientCharReport.pdf [On-line].

• Sajan, A., Corneil, T., & Grzybowski, S. (1998). The street value of prescription drugs.Canadian Medical Association Journal, 159, 139-142.

• SAMHSA (2006).The NSDUH Report: How young adults obtain prescription pain relievers for nonmedical usage SAMHSA.

• Schepis, T. & Krishnan-Sarin, S. (2008). Characterizing adolescent prescription misusers: A population-based study.Journal of the American Academy of Child & Adolescent Psychiatry, 47, 745-754.

• Schiralli, V. & McIntosh, M. (1987). Benzodiazepines: Are we overprescribing?Canadian Family Physician, 33, 927-933.

• Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.BMC Medical Research Methodology,7.

• Shorr, R., Griffin, M., Daugherty, J., & Ray, W. (1992). Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene.Journal of Gerontology, 47, M111-115.

• Sigmon, S. (2006). Characterizing the emerging population of prescription opioid abusers.American Journal on Addictions, 15, 208-212.

• Silversides, A. (2009). Ontario takes aim at painkiller abuse. http://www.cmaj.ca/earlyreleases/1sept09_opioid.shtml [On-line].

• Simoni-Wastila, L. (2001). Balancing diversion control and medical necessity: the case of prescription drugs and abuse potential.Substance Use and Misuse, 36, 1275-1296.

• Simoni-Wastila, L., Ross-Degnan, D., Mah, C., Gao, X., Brown, J., Cosler, L. et al. (2004a). A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in Medicaid patients with chronic psychiatric and neurologic disorders.Clinical Therapeutics, 26, 322-336.

• Simoni-Wastila, L. (2000). The use of abusable prescription drugs: the role of gender.Journal of Women's Health and Gender-Based Medicine, 9, 289-297.

• Simoni-Wastila, L., Ritter, G., & Strickler, G. (2004b). Gender and other factors associated with the nonmedical use of abusable prescription drugs.Substance Use and Misuse, 39, 1-23.

• Simoni-Wastila, L. & Strickler, G. (2004). Risk factors associated with problem use of prescription drugs.American Journal of Public Health, 94, 266-268.

• Smith, M. Y. & Woody, G. (2005). Nonmedical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: patterns, user characteristics, and management options.Curr.Psychiatry Rep., 7, 337-343.

• Spiller, H., Lorenz, D., Bailey, E., & Dart, R. (2009). Epidemiological trends in abuse and misuse of prescription opioids.Jounal of Addictive Diseases, 28, 130-136.

• Sproule, B., Brands, B., Li, S., & Catz-Biro, L. (2009). Changing patterns in opioid addiction. Characterizing users of oxycodne and other opioids.Can Fam Physician, 55, 68-69.

• Sproule, B., Busto, U., Somer, G., Romach, M., & Sellers, E. (1999). Characteristics of dependent and nondependent regular users of codeine.Journal of Clinical Psychopharmacology, 19, 367-372.

• Stevens, K. & The WInnipeg Site Network Team (2006).CCENDU: Winnipeg 2006 Report Manitoba: Addictions Foundation of Manitoba, CCENDU.

• Stevenson, F., Barry, C., Britten, N., Barber, N., & Bradley, C. (2000). Doctor-patient communication about drugs: the evidence for shared decision making.Social Science and Medicine, 50, 829-840.

• Strang, D. & Rashiq, S. (2005). The illicit sale of prescribed opioid medications in Edmonton, Alberta.Pain Research and Management, 10, 188-189.

• Subramaniam, G. & Stitzer, M. (2009). Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder.Drug and Alcohol Dependence, 101, 13-19.

• Substance Abuse and Mental Health Administration (SAMHSA) (2008a). Drug Abuse Warning Network, 2006: National estimates of drug-related emergency department visits. http://dawninfo.samhsa.gov/files/ED2006/DAWN2k6ED.pdf [On-line].

• Substance Abuse and Mental Health Administration (SAMHSA) (2008b). Results from the 2007 National Survey on Drug Use and Health: National findings. http://www.alcoholandcrime.org/images/uploads/pdf_research/nsduh_2007.pdf[On-line].

• Surratt, H., Inciardi, J., & Kurtz, S. P. (2006). Prescription opioid abuse among drug-involved street-based sex workers.Journal of Opioid Management, 2, 283-289.

• Tyndall, M., Kerr, T., Zhang, R., King, E., Montaner, J., & Wood, E. (2006). Attendance, drug use patterns and referrals made from North America's first supervised injection facility.Drug and Alcohol Dependence, 83, 193-198.

• Wall, R., Rehm, J., Fischer, B., Brands, B., Gliksman, L., Stewart, J. et al. (2000). Social costs of untreated opiate use.Journal of Urban Health, 77, 688-722.

• Wardman, D., Khan, N., & el-Guebaly, N. (2002). Prescription medication use among an aboriginal population accessing addiction treatment.Canadian Journal of Psychiatry, 47, 355-360.

• Wastila, L. & Bishop, C. (1996). The influence of multiple copy prescription programs on analgesic utilization.Journal of Pharmaceutical Care in Pain & Symptom Control, 4, 3-19.

• Webster, L., Bath, B., & Medve, R. (2009). Opioid formulations in development designed to curtail abuse: who is the target?Expert Opinion on Investigational Drugs, 18, 255-263.

• Weintraub, M., Singh, S., Byrne, L., Maharaj, K., & Guttmacher, L. (1991). Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.Journal of the American Medical Association, 266, 2392-2397.

• Wild, C., Wolfe, J., Newton-Taylor, M., & Kang, H. (2008). Prescription drug misuse in Edmonton and Alberta: A rapid assessment. http://www.uofaweb.ualberta.ca/amhrl/pdf/Wild_Wolfe_Newton-Taylor_Kang_2008_Prescription_Drug_Misuse.pdf[On-line].

• Wild, T., Prakash, M., O'Connor, H., Taylor, M., Edwards, J., & Predy, G. (2003). Injection drug use in Edmonton's inner city: A multimethod study University of Alberta: Addiction and Mental Health Research Laboratory, Centre for Health Promotion Studies and Department of Public Health Sciences.

• Zacny, J., Bigelow, G., Compton, P., Foley, K., Iguchi, M., & Sannerud, C. (2003). College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug and Alcohol Dependence, 69, 215-232.

• Previous Page
• Table of Contents